Recent Developments and Future Directions of Sympathetic Nervous Function Imaging-Reference-Cited by-同舟云学术

Recent Developments and Future Directions of Sympathetic Nervous Function Imaging

Published:2016 Issue:1 Volume:2 Page:146-151
ISSN:2189-3926
Container-title:Annals of Nuclear Cardiology
language:en
Short-container-title:

Author:

Nakata Tomoaki¹,Nakata Kei²,Hashimoto Akiyoshi²

Affiliation:

1. Department of Cardiology, Hakodate Goryoukaku Hospital

2. Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine

Publisher

The Japanese Society of Nuclear Cardiology

Link

https://www.jstage.jst.go.jp/article/anc/2/1/2_146/_pdf

Reference39 articles.

1. 1. Jacobson AF, Senior R, Cerqueira MD, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in chronic heart failure. Results of the prospective ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart failure) study. J Am Coll Cardiol 2010; 55: 2212-21.

2. 2. Nakata T, Nakajima K, Yamashina S, et al. A pooled analysis of multicenter cohort studies of I-123-mIBG cardiac sympathetic innervation imaging for assessment of long-term prognosis in chronic heart failure. J Am Coll Cardiol Cardiovascular Imag 2013; 6: 772-84.

3. 3. Verschure DO, Veltman CE, Manrique A, et al. For what endpoint does myocardial ¹²³I-MIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? Results of a pooled individual patient data meta-analysis. Eur Heart J Cardiovasc Imaging 2014; 15: 996-1003.

4. 4. Merlet P, Valette H, Dubois-Randé JL, et al. Prognostic value of cardiac MIBG imaging in patients with heart failure. J Nucl Med 1992; 33: 471-7.

5. 5. Nakata T, Miyamoto K, Doi A, et al. Cardiac death prediction and impaired cardiac sympathetic innervations assessed by metaiodobenzylguanidine in patients with failing and non-failing heart. J Nucl Cardiol 1998; 5: 579-90.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of therapeutic effects of statin on cardiac sympathetic nerve activity and cardiac events in patients with ischemic cardiomyopathy and mild to moderate heart failure;Nuclear Medicine Communications;2019-02

2. Area at risk can be assessed by iodine-123-meta-iodobenzylguanidine single-photon emission computed tomography after myocardial infarction;Nuclear Medicine Communications;2018-02

3. Focus Issue: Cardiac Sympathetic Nervous System Imaging from JSNC/ASNC Joint Session in 26^thJSNC Annual Scientific Meeting;Annals of Nuclear Cardiology;2016